Drug Trial Radar · NCT00255424
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
Last checked: Nov 20, 2026Latest source record: Jan 9, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
304
Actual
Start
May 2004
Primary completion
Not stated
Study completion Aug 2006
Sponsor
- Lead sponsor
- AMAG Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 21, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will evaluate the safety and efficacy of a new intravenously administered iron drug to treat anemia in patients with chronic kidney disease who are not on dialysis.
Conditions
- Anemia
Interventions
ferumoxytol or oral ironDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- The mean change in hemoglobin from baseline.
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Encino, California
Site not named
Riverside, California
Site not named
Tarzana, California
Site not named
Ocala, Florida
Site not named
Shreveport, Louisiana
Site not named
Shreveport, Louisiana
Site not named
Springfield, Massachusetts
Site not named
Detroit, Michigan
Site not named
Flushing, New York
Site not named
Orchard Park, New York
Site not named
Columbus, Ohio
Site not named
Hershey, Pennsylvania
Site not named
Lancaster, Pennsylvania
Site not named
Chattanooga, Tennessee
Site not named
Knoxville, Tennessee
Site not named
Houston, Texas
Site not named
Fairfax, Virginia
Site not named
Bluefield, West Virginia
Site not named
Appleton, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.